Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Suzhou Novoprotein Scientific Co's share price is ¥34.76.
Suzhou Novoprotein Scientific Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ¥2.13. Hence, Suzhou Novoprotein Scientific Co's PS Ratio for today is 16.29.
Good Sign:
Suzhou Novoprotein Scientific Co Ltd stock PS Ratio (=15.94) is close to 3-year low of 15.03.
During the past 8 years, Suzhou Novoprotein Scientific Co's highest 3-Year average Revenue per Share Growth Rate was 89.30% per year. The lowest was -40.20% per year. And the median was -18.80% per year.
Back to Basics: PS Ratio
Suzhou Novoprotein Scientific Co (SHSE:688137) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Suzhou Novoprotein Scientific Co PS Ratio Related Terms
Suzhou Novoprotein Scientific Co PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688137 vs VRTX, REGN, RVMD: PS Ratio Comparison
For the Biotechnology subindustry, Suzhou Novoprotein Scientific Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Suzhou Novoprotein Scientific Co PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Suzhou Novoprotein Scientific Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Suzhou Novoprotein Scientific Co's PS Ratio falls into.
Suzhou Novoprotein Scientific Co PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Suzhou Novoprotein Scientific Co's Share Price of today is ¥34.76. Suzhou Novoprotein Scientific Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.13.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Suzhou Novoprotein Scientific Co (SHSE:688137) has a PS Ratio of 16.29 as of Jul. 29, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Suzhou Novoprotein Scientific Co and its competitors. This is 13% below median its historical median of 18.68. Over the past decade, Suzhou Novoprotein Scientific Co's PS Ratio has ranged from 13.49 to 24.25. According to the industry distribution chart, Suzhou Novoprotein Scientific Co ranks #581 out of 929 companies in the Biotechnology industry, placing it in the top 62.5%.
Is Suzhou Novoprotein Scientific Co's PS Ratio too high?
Suzhou Novoprotein Scientific Co's current PS Ratio of 16.29 is 13% below median its 10-year median of 18.68. Over the past 10 years, this metric has ranged from a low of 13.49 to a high of 24.25. The Biotechnology industry median PS Ratio is 9.00. Suzhou Novoprotein Scientific Co's value of 16.29 is 81% above this industry median. Based on the distribution chart, Suzhou Novoprotein Scientific Co ranks #581 out of 929 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Suzhou Novoprotein Scientific Co has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Suzhou Novoprotein Scientific Co's PS Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Suzhou Novoprotein Scientific Co ranks #581 out of 929 companies for PS Ratio. This places Suzhou Novoprotein Scientific Co in the lower half of its industry. The industry median PS Ratio is 9.00. Suzhou Novoprotein Scientific Co's value of 16.29 is 81% above this benchmark. Historically, Suzhou Novoprotein Scientific Co's own PS Ratio has ranged from 13.49 to 24.25 over the past decade. While the company's 10-year median is 18.68 vs. the industry median of 9.00, Suzhou Novoprotein Scientific Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.00, based on 929 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Suzhou Novoprotein Scientific Co's current PS Ratio of 16.29 is 81% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Suzhou Novoprotein Scientific Co and its competitors. For the Biotechnology industry, the median PS Ratio is 9.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Suzhou Novoprotein Scientific Co's current PS Ratio is 16.29, which is 13% below median its own 10-year median of 18.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzhou Novoprotein Scientific Co stock overvalued right now?
Based on GuruFocus' analysis, Suzhou Novoprotein Scientific Co (SHSE:688137) is currently considered Fairly Valued. The stock's GF Value™ is ¥37.73, compared to a current price of ¥34.76 — trading 7.9% below its estimated fair value. The current PS Ratio is 16.29, which is 13% below median its 10-year median of 18.68 and 81% above the Biotechnology industry median of 9.00. Suzhou Novoprotein Scientific Co's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Suzhou Novoprotein Scientific Co (SHSE:688137), the current PS Ratio is 16.29 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Suzhou Novoprotein Scientific Co (SHSE:688137) Overvalued in 2026?
Based on GuruFocus' analysis, Suzhou Novoprotein Scientific Co stock appears to be undervalued.
The current stock price of ¥34.76 is trading 7.9% below its estimated GF Value™ of ¥37.73.
GuruFocus considers Suzhou Novoprotein Scientific Co to be Fairly Valued.
Key valuation signals for SHSE:688137:
PS Ratio: 16.29 (13% below median its 10-year median of 18.68)
GF Value™: ¥37.73 vs. price of ¥34.76 (7.9% below fair value)
Industry Position: 81% above the Biotechnology median (#581 of 929)
No single metric tells the full story. See the SHSE:688137 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Suzhou Novoprotein Scientific Co Business Description
Suzhou Novoprotein Scientific Co Ltd is a high-tech enterprise focusing on recombinant protein application solutions. Its main business is the research and development of target and cytokine proteins, recombinant antibodies, enzymes, and reagents, Production and sales, and providing related technical services.
62GF Score
Get the complete analysis for SHSE:688137
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688137 has been successfully added to your 
